Author

C. Preudhomme

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. ROUMIER· 2 shared H. Dombret· 2 shared M. CHEOK· 2 shared A. Barthelemy· 1 shared A. Bongiovanni· 1 shared A. G. X. Zeng· 1 shared A. K. Kheirallah· 1 shared A. Krzywon· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. ROUMIER

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 20, 2023

Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia

F. Gonzales, P. Peyrouze, T. Boyer…·M. CHEOK

This study identifies CD81 as a marker of aggressive AML and shows anti-CD81 therapy improves survival in AML models.

DOI 10.1101/2023.09.20.558656

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJan 25, 2022

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in AML

A. G. X. Zeng, S. Bansal, L. Jin…·J. E. Dick

This study identifies a cellular hierarchy framework in AML that links disease heterogeneity with drug response and develops a 7-gene biomarker predictive of drug sensitivity.

DOI 10.1038/s41591-022-01819-x

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivDec 10, 2019

A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis

J. Bond, A. Krzywon, L. Lhermitte…·E. Macintyre

The paper identifies a transcriptomic continuum of differentiation arrest in acute leukemias, finding that myeloid/T-lymphoid interface leukemias (IALs) correlate with poor prognosis in AML.

DOI 10.1038/s41375-020-0965-z

humanbulk RNA-seq

𝕏 PostBluesky